STAT3 inhibition reduces macrophage number and tumor growth in neurofibroma. Read more about STAT3 inhibition reduces macrophage number and tumor growth in neurofibroma.
Overexpression-mediated activation of MET in the Golgi promotes HER3/ERBB3 phosphorylation. Read more about Overexpression-mediated activation of MET in the Golgi promotes HER3/ERBB3 phosphorylation.
The pleiotropic effects of TNFα in breast cancer subtypes is regulated by TNFAIP3/A20. Read more about The pleiotropic effects of TNFα in breast cancer subtypes is regulated by TNFAIP3/A20.
Notch2 controls hepatocyte-derived cholangiocarcinoma formation in mice. Read more about Notch2 controls hepatocyte-derived cholangiocarcinoma formation in mice.
Regulation of inside-out β1-integrin activation by CDCP1. Read more about Regulation of inside-out β1-integrin activation by CDCP1.
Combined BET bromodomain and CDK2 inhibition in MYC-driven medulloblastoma. Read more about Combined BET bromodomain and CDK2 inhibition in MYC-driven medulloblastoma.
TWIST1 induces expression of discoidin domain receptor 2 to promote ovarian cancer metastasis. Read more about TWIST1 induces expression of discoidin domain receptor 2 to promote ovarian cancer metastasis.
Epidermal growth factor receptor and EGFRvIII in glioblastoma: signaling pathways and targeted therapies. Read more about Epidermal growth factor receptor and EGFRvIII in glioblastoma: signaling pathways and targeted therapies.
Inhibition of WNT signaling attenuates self-renewal of SHH-subgroup medulloblastoma. Read more about Inhibition of WNT signaling attenuates self-renewal of SHH-subgroup medulloblastoma.
GATA3 targets semaphorin 3B in mammary epithelial cells to suppress breast cancer progression and metastasis. Read more about GATA3 targets semaphorin 3B in mammary epithelial cells to suppress breast cancer progression and metastasis.
